Literature DB >> 18286427

Acute hyperglycemia rapidly suppresses endothelium-dependent arterial dilation in first-degree relatives of type 2 diabetic patients.

G D Xiang1, H L Sun, J Hou, L Yue, L Xu.   

Abstract

OBJECTIVE: Previous studies showed that endothelium-dependent arterial dilation is impaired in first-degree relatives of type 2 diabetes in the fasting state. In the present study, we examined whether endothelial dysfunction occurs when acute hyperglycemia is induced by oral glucose loading in this cohort. PATIENTS AND METHODS: This study included 32 normal glucose tolerant subjects. Of them, 17 with a family history (FH) of type 2 diabetic parents (FH+) and 15 with no first-degree relative with diabetes or coronary artery disease (FH-). The examination of vascular function was performed in fasting state and repeated 1 and 2 hours after a 75-g oral glucose loading by high resolution ultrasound.
RESULTS: Endothelium- dependent arterial dilation in FH+ group were significantly lower than those in FH- before and after oral glucose loading (5.12+/-0.61% vs 6.03+/-0.56%, fasting; 4.0+/-0.65% vs 5.70+/-0.42%, 1 h; 4.43+/-0.61% vs 5.82+/-0.67% 2 h, p<0.05 each). In FH+ group, endothelium-dependent arterial dilation decreased significantly at 60 min (4.0+/-0.65% vs 5.12+/-0.61%, p<0.01) and increased markedly from 60 min at 120 min (4.43+/-0.61% vs 4.0+/-0.65%, p<0.05), which was still significantly lower than baseline (4.43+/-0.61% vs 5.12+/-0.61%, p<0.01) . In FH- group, however, the arterial dilation did not differ significantly among the three time points (p 0.05). In multiple regression analysis, endothelium-dependent arterial dilation was significantly correlated to FH+(r=-0.302, p<0.01). In addition, endothelium-dependent arterial dilation showed a correlation with plasma glucose (r=-0.460, p<0.01) and TBARS (r=-0.382, p<0.01) during OGTT in FH+ subjects.
CONCLUSION: Significant endothelial dysfunction is present in the fasting state, hyperglycemia in response to oral glucose loading rapidly suppresses endothelium-dependent arterial dilation in FH+ subjects, probably through increased production of oxygen-derived free radicals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18286427     DOI: 10.1055/s-2007-984478

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

1.  The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance.

Authors:  Kazunari Suzuki; Kentaro Watanabe; Shoko Futami-Suda; Hiroyuki Yano; Masayuki Motoyama; Noriaki Matsumura; Yoshimasa Igari; Tatsuya Suzuki; Hiroshi Nakano; Kenzo Oba
Journal:  Cardiovasc Diabetol       Date:  2012-08-14       Impact factor: 9.951

2.  Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients.

Authors:  Ignatios Ikonomidis; George Pavlidis; Maria Tsoumani; Foteini Kousathana; Konstantinos Katogiannis; Damianos Tsilivarakis; John Thymis; Aikaterini Kountouri; Emmanouil Korakas; Loukia Pliouta; Athanasios Raptis; John Parissis; Ioanna Andreadou; Vaia Lambadiari
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

3.  Endothelial function following interval exercise plus low-calorie diet treatment in obese females.

Authors:  Nicole M Gilbertson; Stephanie L Miller; Natalie Z M Eichner; Steven K Malin
Journal:  Physiol Rep       Date:  2019-09

4.  Oxidative Stress and Arginine/Nitric Oxide Pathway in Red Blood Cells Derived from Patients with Prediabetes.

Authors:  Sonia Eligini; Benedetta Porro; José Pablo Werba; Nicolò Capra; Stefano Genovese; Arianna Greco; Viviana Cavalca; Cristina Banfi
Journal:  Biomedicines       Date:  2022-06-14

5.  Relationship between postprandial glucose level and carotid artery stiffness in patients without diabetes or cardiovascular disease.

Authors:  Kentaro Watanabe; Tatsuya Suzuki; Motoshi Ouchi; Kazunari Suzuki; Makoto Ohara; Masao Hashimoto; Hidetoshi Yamashita; Masaru Okazaki; Kazuhito Ishii; Kenzo Oba
Journal:  BMC Cardiovasc Disord       Date:  2013-02-26       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.